Latest Content

A new US-based grant program seeks to create training content for health care providers who want to be able to deliver investigational COMP360 psilocybin treatment.

Explore how sigma‑1 receptors shape ER–mitochondria signaling, calm neuroinflammation, and inspire therapies from fluvoxamine to dextromethorphan.

Psychiatry training must catch up with chatbot literacy, intake, safety, ethics, and supervised AI integration.

With Artemis II’s journey in mind, a psychiatrist urges mental health action on climate denial, resilience, and saving Earth before it’s too late.

A pharma expert and clinician shares perspectives on developing treatments.

“Each person the right to tell their own story in their own way”: An Italian-Canadian psychiatrist traces family journeys across 3 countries, revealing migration’s lessons on identity, belonging, and resilience.

Exercise boosts recovery in depression and psychosis, and improves cognition and quality of life; clinicians can now use the 5A model to make movement a routine psychiatric tool.

Artemis II astronauts spark a psychiatrist’s look at “joy trains,” music, and meaning—practical ways teams rekindle joy and prevent burnout.

New ASAM youth criteria redefine SUD care with brain-stage levels, chronic monitoring, detox safety, and family-centered support.

From Artemis II’s fiery return to life after prison or vacation, this article shows how reentry stress becomes a skill for growth.

To prescribe or not to prescribe?

Deep intracranial frequency stimulation 77.5 Hz high-gamma approach was associated with statistically significant reductions in self-injury behaviors and depressive symptoms in female adolescents with nonsuicidal self-injury.